Emboline
Company

Last deal

$55M

Amount

Series D

Stage

25.05.2021

Date

4

all rounds

$80M

Total amount

General

About Company
Emboline develops a device that protects patients from embolic risks during cardiovascular procedures.

Industry

Sector :

Subsector :

Keywords :

founded date

08.08.2011

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

Emboline's Emboliner® Catheter offers complete protection of the brain and other critical organs by capturing and removing emboli produced during percutaneous heart valve repair and replacement procedures. The catheter provides protection of the arterial bed and conforms to a wide range of patient anatomies, while the expandable access port accommodates a variety of procedural devices. The device is designed to prevent stroke-producing debris from being released during transcatheter heart procedures, making it a game-changer in the medical device industry.
Contacts